These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The stability of human pepsins in stored gastric juice. Whitecross DP, Piper DW. Scand J Gastroenterol; 1975 Jul; 10(4):395-9. PubMed ID: 239449 [Abstract] [Full Text] [Related]
5. Mucus degradation by pepsin: comparison of mucolytic activity of human pepsin 1 and pepsin 3: implications in peptic ulceration. Pearson JP, Ward R, Allen A, Roberts NB, Taylor WH. Gut; 1986 Mar; 27(3):243-8. PubMed ID: 3084340 [Abstract] [Full Text] [Related]
6. Mucosal protective effects of ecabet sodium: pepsin inhibition and interaction with mucus. Pearson JP, Roberts NB. Clin Sci (Lond); 2001 Apr; 100(4):411-7. PubMed ID: 11256980 [Abstract] [Full Text] [Related]
7. Physiological study of pH stability and sensitivity to pepsin of human gastric lipase. Ville E, Carrière F, Renou C, Laugier R. Digestion; 2002 Apr; 65(2):73-81. PubMed ID: 12021480 [Abstract] [Full Text] [Related]
18. The pepsins of human gastric juice. Separation by electrophoresis and chromatography; the influence of gastric disease and ambient pH. Whitecross DP, Clarke AD, Piper DW. Scand J Gastroenterol; 1974 Nov; 9(8):711-7. PubMed ID: 4610714 [No Abstract] [Full Text] [Related]
19. Review article: human pepsins - their multiplicity, function and role in reflux disease. Roberts NB. Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 2():2-9. PubMed ID: 16939427 [Abstract] [Full Text] [Related]
20. Effects of the new anti-ulcer drug ecabet sodium (TA-2711) on pepsin activity. I. Inactivation of enzyme protein. Ito Y, Nakamura S, Onoda Y, Sugawara Y, Takaiti O. Jpn J Pharmacol; 1993 Jun; 62(2):169-74. PubMed ID: 8371515 [Abstract] [Full Text] [Related] Page: [Next] [New Search]